oxymetholone has been researched along with Dysmyelopoietic Syndromes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, EJ; Jeon, M; Kang, H; Kang, YA; Lee, JH; Lee, KH; Lee, YS; Park, HS; Seol, M; Woo, JM | 1 |
| Han, DH; Hong, DS; Ji, YS; Kim, CK; Kim, HJ; Kim, HK; Kim, KH; Kim, SH; Lee, KT; Lee, MS; Min, CW; Park, SK; Won, JH; Yun, J | 1 |
| Hirose, H; Hosoda, Y; Nakamura, H; Ohishi, A; Sugiura, H; Umezawa, A | 1 |
| Appelbaum, FR; Buckner, CD; Deeg, HJ; Doney, K; McGuffin, R; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
4 other study(ies) available for oxymetholone and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Danazol; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Oxymetholone; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Young Adult | 2019 |
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agents; Microvessels; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxymetholone; Prognosis; Pyridoxine; Retrospective Studies; Survival Rate; Vascular Endothelial Growth Factor A; Young Adult | 2016 |
Fatal splenic rupture in anabolic steroid-induced peliosis in a patient with myelodysplastic syndrome.
Topics: Aged; Anemia, Refractory; Humans; Male; Myelodysplastic Syndromes; Oxymetholone; Peliosis Hepatis; Rupture, Spontaneous; Splenic Diseases; Splenic Rupture | 1991 |
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Methylprednisolone; Myelodysplastic Syndromes; Oxymetholone; T-Lymphocytes | 1987 |